← SynDRA
TALIBEGRON
SynDRA canonical compound SYN0025727 — structure-anchored drug synonym record
| Clinical phase | Phase 2 |
|---|
| Primary target(s) | ADRB3 |
|---|
| Mechanism of action | Adrenergic receptor agonist |
|---|
All known targets
Mechanisms of action (all sources)
- Adrenergic receptor agonist
- ADRB3 AGONIST
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)
Cross-references
Synonyms
- ZD-2079
- Talibegron [INN]
- UNII-M7O3VK2O7W
- M7O3VK2O7W
- talibegronum
- RefChem:187309
- SCHEMBL328977
- orb2815163
- CHEBI:93123
- T202547
- BRD-K64157027-003-01-9
- BRD-K64157027-003-02-7
- DSSTox_CID_28968
- ICID2079
- FH64922
- SCH-417849
- Talibegron hydrochloride [USAN]
- HMS3677I07
- N251Q608VU
- Tox21_113587_1
- ZD 2079 hydrochloride
- talibegron hydrochloride
- HY-15378
- Talibegron hydrochloride (USAN)
- Talibegron hydrochloride
- NCGC00092315-01
- DTXCID9028968
- T23557
- ZD2079
- 4-[2-[[(2R)-2-HYDROXY-2-PHENYLETHYL]AMINO]ETHOXY]-BENZENEACETIC ACID HYDROCHLORIDE
- Talibegron HCl
- NCGC00092315-02
- EX-A15215
- ZD 2079
- UNII-N251Q608VU
- TS-08343
- D02702
- orb1703896
Look up TALIBEGRON in the interactive SynDRA portal →